Delivery Order 75F40123D00001-75F40123F19010
Award Date 3/29/23
Potential Completion Date 10/16/25
Potential Value $286K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Berwyn Heights, MD 20740, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Food and Drug Administration (FDA) awarded a delivery order to Illumina, Inc. for Illumina Reagent Chemistry Kits under a firm fixed-price contract with a ceiling value of approximately $200.6K. The award, issued on March 29, 2023, with an ultimate completion date of October 16, 2025, does not utilize a set-aside designation and will be performed in Laurel, Maryland. Illumina, a San Diego-based biotechnology company specializing in genetic sequencing and genomic analysis technologies,...
- The Food and Drug Administration awarded a delivery order to Illumina, Inc. for Illumina Reagent Chemistry Kits valued at $144,615.89 under a firm fixed-price contract type. The contract was awarded on January 30, 2023, with an ultimate completion date of October 21, 2025, and will be performed in Laurel, Maryland. This delivery order does not utilize a set-aside designation, reflecting Illumina's specialized capabilities in genomic sequencing technologies. The reagent chemistry kits procured...
- The U.S. Food and Drug Administration (FDA) awarded a $684,263.46 delivery order to Illumina, Inc. for Illumina Reagent Chemistry Kits with a firm fixed price structure. The award, issued on June 25, 2025, is scheduled for completion by September 30, 2025, with performance taking place at the FDA's Rockville, Maryland facility. This contract represents a parent-level award with no set-aside designation, reflecting Illumina's specialized technological capabilities in genomic sequencing reagents...
- The Food and Drug Administration (FDA) awarded a delivery order contract to Illumina, Inc. for illumina reagent chemistry kits, with a ceiling value of $162,136.75. The contract, which is structured as a firm fixed price delivery order with no set-aside designation, was awarded on January 30, 2023, and is scheduled for completion by October 21, 2025. Performance will take place in Laurel, Maryland. This delivery order leverages Illumina's specialized expertise as a leading biotechnology...
- The Food and Drug Administration awarded a delivery order to Illumina, Inc. for Illumina Reagent Chemistry Kits valued at $177,986.33 under a Firm Fixed Price contract type. The award, issued on January 15, 2025, with an ultimate completion date of March 31, 2025, represents a modification to de-obligate funds and close out the contract. The work will be performed in Laurel, Maryland, and no set-aside designation was utilized for this procurement. Illumina, Inc., a leading biotechnology...
- This federal contract award to Illumina, Inc. is for the provision of ILLUMINA REAGENT CHEMISTRY KITS to the Food and Drug Administration (FDA), a civilian federal agency. The $23,563.22 Firm Fixed Price Delivery Order contract has an ultimate completion date of September 17, 2025. Illumina, a for-profit manufacturer of genomic sequencing technologies, has been awarded this direct contract without any set-aside designation, indicating the company's specialized capabilities. The award is not...
- This federal contract award, valued at $104,968.99, was issued by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the delivery of Illumina reagent (chemistry) kits, with an ultimate completion date of September 14, 2022. The contract is a firm fixed-price Delivery Order with no set-aside designation. Illumina has a history of providing sequencing systems, reagents, and related services to various federal...
- This is a federal contract award to Illumina, Inc., a biotechnology company specializing in genetic sequencing and genomic analysis technologies. The contract, valued at $219,167.07, is for the provision of Illumina reagent chemistry kits to the Food and Drug Administration (FDA), a civilian agency. The award is a delivery order contract with a firm fixed price, and the ultimate completion date is June 13, 2023. The contract does not have a set-aside designation. Illumina is a well-established...
- The Food and Drug Administration awarded a delivery order valued at $82,062.14 to Illumina, Inc. for Illumina reagent kits. This firm fixed-price delivery order, with an ultimate completion date of July 31, 2025, is being closed out through de-obligation of remaining funds. The work will be performed in Laurel, Maryland. No small business set-aside designation was applied to this award, reflecting Illumina's specialized technological position as a primary source for proprietary sequencing...
- This is a federal contract award to Illumina, Inc., a biotechnology company specializing in genetic sequencing and genomic analysis technologies. The contract, awarded by the Food and Drug Administration (FDA), is for the provision of ILLUMINA REAGENT CHEMISTRY KITS. The contract has a ceiling value of $37,819.42 and an ultimate completion date of August 13, 2023. It is a Delivery Order contract with a Firm Fixed Price pricing type. The contract is not set aside for any specific designation....